Comment[GEAAccession] E-GEAD-343 MAGE-TAB Version 1.1 Investigation Title Aspirin broadly upregulates glutaminolysis-related genes in PIK3CA CRC cells Experiment Description RNA-seq data of HCT-15 cells treated with DMSO or 2 mM aspirin for 24 hr (n=2). To identify differentially regulated pathways affected by aspirin, we performed RNA sequencing analysis of HCT-15 cells treated with DMSO or aspirin, and gene set enrichment analysis (GSEA). Aspirin can behave to imitate glutamine depletion and transcriptionally upregulate glutaminolysis-related genes in PIK3CA-mutated cells. Experimental Design compound treatment design translational bias design replicate design Experimental Factor Name treatment Experimental Factor Type treatment Person Last Name Boku Hirota Person First Name Shogen Kiichi Person Affiliation Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine Person Roles submitter submitter Public Release Date 2020-05-08 Protocol Name P-GEAD-364 P-GEAD-365 P-GEAD-366 P-GEAD-367 P-GEAD-368 Protocol Type sample collection protocol nucleic acid extraction protocol nucleic acid library construction protocol nucleic acid sequencing protocol normalization data transformation protocol Protocol Description Total RNA was extracted from cells using RNeasy Mini Kit (Qiagen) and processed using TruSeq Stranded mRNA Sample Prep Kit (Illumina, San Diego, CA, USA) Total RNA was extracted from cells using RNeasy Mini Kit (Qiagen) and processed using TruSeq Stranded mRNA Sample Prep Kit (Illumina, San Diego, CA, USA) RNA libres were then constructed using TruSeq Stranded mRNA Library Preparation Kit (Illumina,ari San Diego, CA, USA). RNA libres were at 100 bp paired-ends on an Illumina NovaSeq6000 platform. The quantified transcript reads were filtered with 0.5 counts per million (CPM) in at least one sample and transformed, using EdgeR: log2(CPM+c), with pseudocount c =4. SDRF File E-GEAD-343.sdrf.txt Comment[AEExperimentType] RNA-seq of coding RNA Comment[BioProject] PRJDB9390 Comment[Last Update Date] 2020-05-08